🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today GRAIL reported Q3 2024 financial results. Read more: bit.ly/3CmFmpR

We’re wishing Dallas Cowboys' Tad Carper a speedy recovery after learning about his recent cancer diagnosis. We're glad Tad’s cancer was caught early, using multi-cancer early detection testing as a first step. Rx only. See Important Safety Information: galleri.com/safety-informa…

Cancer impacts nearly everyone and early cancer detection can make a significant difference, like it did for the Dallas Cowboys' Tad Carper. We applaud Dak Prescott and his foundation Faith Fight Finish Foundation for raising awareness of the importance of early cancer detection.

Today GRAIL reported fourth quarter and full year 2024 financial results. Read more: bit.ly/41n9knE

Kate Walsh is part of Generation Possible, the first generation with access to multi-cancer early detection (MCED) tests that help screen for many of the deadliest cancers before symptoms appear. Learn more and see Important Safety Information: genpossible.com

Now, unlike the generations before us, we can take more control of our health with multi-cancer early detection (MCED) testing. Learn more and see Important Safety Information: genpossible.com

Learn more about Generation Possible: genpossible.com

Today we welcomed several cancer advocacy organizations to our NC site to tour our state-of-the-art lab and meet with GRAIL senior leaders. It was an incredible opportunity to share our innovative work and explore what is needed to support those impacted by cancer.

This Medical Laboratory Professionals Week, we are recognizing the important work our clinical laboratory personnel and professionals do in the fight against cancer. Thank you for your invaluable contribution to our mission. #MLPW #lab4life #labweek

We’re excited to attend the @aacr Annual Meeting to present new data findings that highlight real-world evidence with the Galleri multi-cancer early detection (MCED) test. See when and where you can find our data presentations: bit.ly/4lMxS1y #AACR25

We will issue first quarter 2025 financial results on Tuesday, May 13, 2025. Register for the live teleconference: bit.ly/4cSEmI9 See more details: bit.ly/42RjYCn

Today we announced a new partnership with athenahealth, which will offer healthcare providers streamlined ordering of the Galleri multi-cancer early detection (MCED) test. Learn more: bit.ly/3H4bh0h

Today GRAIL reported first quarter 2025 financial results. Learn more: bit.ly/44BD5D7

.Erin Polak, GRAIL: 7 out of 10 cancer deaths occur in Medicare beneficiaries. The cost burden is significant. The vast majority of that will be focused on late stage cancer when outcomes are worse & costs are higher. Early detection is a valuable tool. #CancerNationalForum

Lieutenant McFarland, a healthy firefighter, took an #MCED test, leading to a stage 1 #EsophagealCancer diagnosis after diagnostic evaluation. Early detection allowed for a minimally invasive procedure to remove the tumor, helping him avoid chemo and radiation.

Today we announced positive top-line performance and safety results from our registrational PATHFINDER 2 study. Learn more: bit.ly/3SZU9M6

A new episode of #TheCancerSignal podcast featuring Dallas Cowboys Senior VP of Communications, Tad Carper, is coming soon! Stay tuned to hear his personal experience with multi-cancer early detection (MCED) testing.